 Connection
Megan Rech to Fibrinolytic Agents
This is a "connection" page, showing publications Megan Rech has written about Fibrinolytic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.468 |
|
|
|
-
Rech MA, Donahey E, DeMott JM, Coles LL, Peksa GD. The impact of antihypertensive use in the treatment of acute ischemic stroke in patients receiving alteplase. Am J Emerg Med. 2021 12; 50:93-96.
Score: 0.556
-
Rech MA, Bennett S, Donahey E. Pharmacist Participation in Acute Ischemic Stroke Decreases Door-to-Needle Time to Recombinant Tissue Plasminogen Activator. Ann Pharmacother. 2017 Dec; 51(12):1084-1089.
Score: 0.422
-
Mercer KJ, Howington GT, Brown CS, Gilbert BW, Cole K, Acquisto NM, Zimmerman DE, Ray L, Gerberi D, Mattson AE, Faine B, Rech MA. Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle times in acute ischemic stroke: A systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I (PhAST-1)). Am J Emerg Med. 2025 12; 98:57-64.
Score: 0.184
-
Webb AJ, Brown CS, Rech MA. Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase. JAMA. 2022 06 21; 327(23):2354-2355.
Score: 0.148
-
Garg R, Rech MA, Schneck M. Stroke Mimics: An Important Source of Bias in Acute Ischemic Stroke Research. J Stroke Cerebrovasc Dis. 2019 Sep; 28(9):2475-2480.
Score: 0.120
-
Brown CS, Sarangarm P, Faine B, Rech MA, Flack T, Gilbert B, Howington GT, Laub J, Porter B, Slocum GW, Zepeski A, Zimmerman DE. The Emergency Medicine Pharmacotherapy Literature of 2021. Am J Emerg Med. 2022 10; 60:88-95.
Score: 0.037
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|